about
Utility of the Atopy Patch Test in the Diagnosis of Allergic RhinitisStriving for optimal bronchodilation: focus on olodaterolNew combinations in the treatment of COPD: rationale for aclidinium-formoterolDissecting the causes of atopic dermatitis in children: less foods, more mitesDiagnosis of exercise-induced anaphylaxis: current insightsXXIV World Allergy Congress 2015In the strategies to prevent asthma exacerbations, allergic asthma needs specific treatment.The soft computing-based approach to investigate allergic diseases: a systematic review.Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory diseasePreventive actions of allergen immunotherapy: the facts and the effects in search of evidence.Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy.Adherence issues related to sublingual immunotherapy as perceived by allergists.Development of a sublingual allergy vaccine for grass pollinosis.Sinus imaging for diagnosis of chronic rhinosinusitis in children.Diagnosis of chronic rhinosinusitis.Specific immunotherapy by the sublingual route for respiratory allergy.A survey of clinical features of allergic rhinitis in adults.Sublingual immunotherapy in children: facts and needs.Anaphylaxis: an update on its understanding and management.Omalizumab, an anti-immunoglobulin E antibody: state of the art.Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation.Catching allergy by a simple questionnaireAllergen specificity is relevant for immunotherapy prescription in polysensitised childrenChloramine-induced anaphylaxis while showering: a case report.Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy.Shrinking the room for invasive ventilation in hypercapnic respiratory failure.Mucosal immunization application to allergic disease: sublingual immunotherapy.Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adultsImpairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium.Evolution of anti-IgE treatment.Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order.Effects of sublingual immunotherapy on allergic inflammation.Economic studies of immunotherapy: a review.Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.Allergic inflammation and the oral mucosa.Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab.5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study.Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis.Pulmonary rehabilitation as evaluated by clinical trials: an overview.
P50
Q26739724-927ED562-0A25-4856-97D2-E779FB481927Q26752887-3484F61B-4FF2-45F9-8084-05AE37388057Q26765303-772018A0-F564-4550-B34B-088CBA54629CQ27010000-552B6CC4-7874-4105-8DFB-6ACD75D24EA5Q28073240-68E481B5-581F-416B-92F2-4ACDFE2A2196Q28550026-8E4E745C-7955-4EC7-A7B5-75509F2F8FA8Q30901102-BE7ED243-8DEA-4029-AF7A-986F63D5D4FDQ33560390-E11731C2-DF0E-44B5-A7AB-1A42B4FAF4F8Q33592972-182EA43A-78A7-416B-AA00-648EFE4C5104Q33802263-745A98EF-13C3-4F42-B5EC-694CE795F1B4Q33810733-B926D996-35BF-4506-9ED5-3982DA5DF005Q33966098-515A4DE4-79E7-4C53-B957-625410A483C3Q34041905-E310B05F-EDDA-4A4D-8E23-C04E9DEE1DB4Q34148657-81CA3B0D-D31A-4174-9A1B-9A7981DB2B66Q34326935-70135A8B-409F-4D50-AA58-F45A65ACBEC8Q34353492-536E38BB-C0AE-4378-83B0-1BB16FAE566CQ34496568-CBA4371C-321D-4E00-8644-1A94E5844FD3Q34613104-752101FA-EF60-4D78-9458-73240860CBA7Q34616185-93D2CE95-91F2-4160-A304-DE7AF6DB7CEEQ35095218-9DF7F597-0FBC-46A1-8D14-4BC36C4E37BEQ35131478-155CBC92-1E65-49C9-900A-F5AFFF114C29Q35730145-82EDD0A8-2010-4EC8-938A-D3469B0E96B9Q36292802-2E86309A-106A-491F-8573-603F106FAE97Q36297222-D7A995E3-50FC-40E7-A73A-5A4392EF6AE0Q36439082-997437C4-23FF-4ADB-B63C-75A044DE5453Q36694291-17B45393-9BA3-42A8-B4E7-44178906FF0FQ36772713-DBDEC317-CFB2-43C8-BAE8-45BBC4187155Q36791729-4365F7B8-851D-43F0-A166-5D39AB4EB2F2Q36859393-D8C242AE-3CC5-428D-BBFD-4E04E60DDB6CQ36870053-2F6B25F4-DD3C-4A12-85DB-0D8C1CD5D8CBQ37115936-9596DA51-52E9-477B-AB5A-352A1C51C3EEQ37265007-632B2184-9560-48E1-89DB-4F96E2F4E170Q37318081-6F213FA9-43A3-4AAD-9DD3-56F574754787Q37340174-3C08FC63-E22F-4E1E-89EE-55A0B3E6B199Q37348051-F8BD1B35-A5AF-44CA-95E3-CC2B5442F1D7Q37364241-510D9EFA-0D18-4D52-A2B2-D4BD1DFE8181Q37390510-F61F7F7D-490B-42B5-9DF8-0ADC8C553BECQ37550576-57A4F88F-F8D6-47EA-A170-FF1FA9F4B1B8Q37684339-E0BF4154-F693-4605-B464-00B935A78827Q37702299-0A35E4A1-6BAB-482D-B85E-17F4831253A7
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Cristoforo Incorvaia
@ast
Cristoforo Incorvaia
@en
Cristoforo Incorvaia
@es
Cristoforo Incorvaia
@nl
type
label
Cristoforo Incorvaia
@ast
Cristoforo Incorvaia
@en
Cristoforo Incorvaia
@es
Cristoforo Incorvaia
@nl
prefLabel
Cristoforo Incorvaia
@ast
Cristoforo Incorvaia
@en
Cristoforo Incorvaia
@es
Cristoforo Incorvaia
@nl
P108
P31
P496
0000-0002-3965-7988